03 Feb 2022 Fundraising

Leukaemia UK awarded Christmas Grant to support life-saving research

Leukaemia UK are delighted to have been awarded a special Christmas Grant from Kusuma Trust UK.

The grant of £10,000 will support the life-saving leukaemia research projects that Leukaemia UK funds across the UK. This includes Leukaemia UK’s prestigious John Goldman Fellowships which fund novel research projects by early career researchers into treatments for leukaemia and Project Grants funding experienced researchers advancing the fundamental understanding of the disease.

Fiona Hazell, Chief Executive of Leukaemia UK, said “We are thrilled to have been awarded this grant from Kusuma Trust UK, which will help to support Leukaemia UK’s life-saving research programmes into kinder and more effective treatments. Kusuma Trust’s support will help us to progress the research that matters most to the tens of thousands of families impacted by a leukaemia diagnosis.”

The Kusuma Trust UK is a family led philanthropic trust established in 2010. The Trust gives grants to organisations based on shared values and mutual interests in the UK, Gibraltar and India. Its current areas of interest are creating access to opportunities, improving health and well-being, and investing in our communities and environment.”

The Kusuma Trust said “We were very impressed to learn about Leukaemia UK’s research into leukaemia and other blood cancers and related disorders, and how they are pioneering the development of improved care and support to those affected. We hope that our funding will help to continue doing this important work.”

This generous grant will go towards funding kinder and more effective treatments for leukaemia, such as the research being carried out by Dr Samanta Mariani into the role of macrophages in cases of infant leukaemia or by Dr Daniel Coleman into developing kinder treatments by targeting mutated RAS genes.

Related posts

A research breakthrough targets cancer over healthy tissue, bringing possibility of a new treatment option for most deadly type of leukaemia

1 August 2022

A research breakthrough targets cancer over healthy tissue, bringing possibility of a new treatment option for most deadly type of leukaemia

A new scientific paper published on 22nd June in Science Translational Medicine, announced a breakthrough by Leukaemia UK-funded scientist Dr William Grey that could lead to a vital new treatment option for…

Can the unique differences between stem cells tell us how well CML treatment will work?

22 May 2023

Can the unique differences between stem cells tell us how well CML treatment will work?

What if we could predict how chronic myeloid leukaemia (CML) patients will respond to treatment? Could the unique signatures of CML stem cells hold the key to personalising treatment for…

Jelly bellies, yellow teeth and hairy ears – parents reveal the most EMBARRASSING questions their children have asked

21 August 2023

Jelly bellies, yellow teeth and hairy ears – parents reveal the most EMBARRASSING questions their children have asked

A new survey has revealed the most embarrassing, awkward and often hilarious questions that parents or grandparents surveyed have been asked by children. The survey was undertaken by charities Leukaemia…

Leukaemia UK John Goldman Fellow awarded Professorship

28 November 2022

Leukaemia UK John Goldman Fellow awarded Professorship

Talented blood cancer researcher, Vignir Helgason, was awarded a Leukaemia UK John Goldman Fellowship in 2015, for his research into chronic myeloid leukaemia (CML). Since then, his research career has…